BioSpace News Archive

AMRA Medical announces it has entered into a new collaboration with Hamad Medical Corporation.

Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that its Japanese patent for the technology “Protease Inhibitor – Containing Compositions, Compositions Comprising Same, and Methods for Producing and Using Same” has been granted by the Japanese Patent Office

AN2 Therapeutics, Inc. (“AN2"), a newly-formed biopharmaceutical company focused on the research, development, and commercialization of novel medicines targeting infectious diseases, today announced that it has raised $12 million in a Series A financing led by Mountain Group Partners and joined by Adjuvant Capital, Brii Biosciences, and BioRock Ventures

Clinical Trial to Validate Auricular Neurostimulation Solution for Relieving Withdrawal Symptoms in Adults

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NYSE: CGC) is aware of yet-to-be certified securities class-action suits having been filed in the United States that allege that the Company issued certain false and misleading statements.

Titan Medical Inc. announced that Company management will be participating in two upcoming investor conferences.

Technavio has announced its latest market research report titled global intrauterine contraceptive devices market 2019-2023

Centogene is a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies.

HMS Holdings Corp. (Nasdaq: HMSY) today announced it has signed a definitive agreement to acquire Accent, a payment accuracy and cost containment business

New version of Imprivata OneSign® delivers secure, transparent access to on-prem and cloud applications to support healthcare delivery organizations’ hybrid environment